Immune derangements in patients with myelofibrosis: the role of Treg, Th17, and sIL2Rα.
Myelofibrosis (MF), including primary myelofibrosis, post-essential thrombocythemia MF, and post-polycythemia vera MF, has been reported to be associated with autoimmune phenomena. IMiDs have been reported to be effective in some patients with MF, presumably for their immune-modulator effects. We th...
Main Authors: | Jen C Wang, Hemant Sindhu, Chi Chen, Ajay Kundra, Muhammad I Kafeel, Ching Wong, Stephen Lichter |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4368690?pdf=render |
Similar Items
-
The Expression of Notch/Notch Ligand, IL-35, IL-17, and Th17/Treg in Preeclampsia
by: Weiping Cao, et al.
Published: (2015-01-01) -
The Dynamics of Treg/Th17 and the Imbalance of Treg/Th17 in Clonorchis sinensis-Infected Mice.
by: Chao Yan, et al.
Published: (2015-01-01) -
IL-23/IL-17 axis and soluble receptors isoforms sIL-23R and sIL-17RA in patients with rheumatoid arthritis-presenting periodontitis
by: Bernard-Medina, A.G, et al.
Published: (2021) -
Treg/IL-17 ratio and Treg differentiation in patients with COPD.
by: Yang Jin, et al.
Published: (2014-01-01) -
Suppressive IL-17A+Foxp3+ and ex-Th17 IL-17AnegFoxp3+ Treg cells are a source of tumour-associated Treg cells
by: Stephanie Downs-Canner, et al.
Published: (2017-03-01)